Expertise in
15
conditions

Dr. Donald Kohn

Pediatrics
Ronald Reagan UCLA Medical Center
757 Westwood Plz, 
Los Angeles, CA 
Clinical Trials:Currently Recruiting for 1 Trial
42 Years of Experience
Expertise in
15
conditions
Ronald Reagan UCLA Medical Center
757 Westwood Plz, 
Los Angeles, CA 

Overview

Donald Kohn is a Pediatrics provider in Los Angeles, California. Dr. Kohn has been practicing medicine for over 42 years is highly rated in 15 conditions, according to our data. His top areas of expertise are Severe Combined Immunodeficiency (SCID), Adenosine Deaminase Deficiency, X-Linked Severe Combined Immunodeficiency, Hemoglobinopathy, and Bone Marrow Transplant.

His clinical research consists of co-authoring 199 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Pediatrics

Licenses

Pediatric Hematology-Oncology in CA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Optima Health
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles, CA 90095
Other Locations
UCLA Developmental-Behavioral Pediatrics
200 UCLA Medical Plz Ste 265, Los Angeles, CA 90095

Additional Areas of Focus

Dr. Kohn has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Transplantation of CRISPRCas9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease
Transplantation of CRISPRCas9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease
Enrollment Status: Recruiting
Publish Date: September 20, 2024
Intervention Type: Drug
Study Drug: CRISPR_SCD001
Study Phase: Phase 1/Phase 2
Clinical Research Study of Autologous Stem Cell Transplantation for Sickle Cell Disease (SCD) Using Peripheral Blood CD34+ Cells Modified With the Lenti/G-βAS3-FB Lentiviral Vector
Clinical Research Study of Autologous Stem Cell Transplantation for Sickle Cell Disease (SCD) Using Peripheral Blood CD34+ Cells Modified With the Lenti/G-βAS3-FB Lentiviral Vector
Enrollment Status: Completed
Publish Date: December 17, 2025
Intervention Type: Biological
Study Drug: ?AS3-FB vector transduced peripheral blood CD34+ cells
Study Phase: Phase 1/Phase 2
A Two-Part, Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
A Two-Part, Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
Enrollment Status: Completed
Publish Date: May 02, 2025
Intervention Type: Biological
Study Drug: Lentiviral G1XCGD Gene Therapy
Study Phase: Phase 1/Phase 2
Multi-site Phase I/II Trial Evaluating the Treatment of SCID-X1 Patients With Retrovirus-mediated Gene Transfer
Multi-site Phase I/II Trial Evaluating the Treatment of SCID-X1 Patients With Retrovirus-mediated Gene Transfer
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Biological
Study Drugs: Busulfan, Bone Marrow Cell Infusion
Study Phase: Phase 1/Phase 2
Efficacy and Safety of Cryopreserved Formulation of Autologous CD34+ Hematopoietic Stem Cells Transduced Ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for Human ADA Gene in Subjects With Severe Combined Immunodeficiency Due to ADA Deficiency
Efficacy and Safety of Cryopreserved Formulation of Autologous CD34+ Hematopoietic Stem Cells Transduced Ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for Human ADA Gene in Subjects With Severe Combined Immunodeficiency Due to ADA Deficiency
Enrollment Status: Completed
Publish Date: August 03, 2022
Intervention Type: Genetic, Drug
Study Phase: Phase 1/Phase 2
A Single Arm, Open Label Clinical Study to Enable Process Validation of Commercial Grade Ex Vivo Hematopoietic Stem Cell Gene Therapy (OTL-101) in Subjects With Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency (ADA-SCID)
A Single Arm, Open Label Clinical Study to Enable Process Validation of Commercial Grade Ex Vivo Hematopoietic Stem Cell Gene Therapy (OTL-101) in Subjects With Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency (ADA-SCID)
Enrollment Status: Withdrawn
Publish Date: August 03, 2022
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials

199 Total Publications

Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.
Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.
Journal: Obstetrical & gynecological survey
Published: December 30, 2025
Similar Doctors
Expertise in
10
conditions
Dr. Federico Velez
Pediatrics
Expertise in
10
conditions
Dr. Federico Velez
Pediatrics

Sherwin J. Isenberg MD Inc

100 Stein Plz, 
Los Angeles, CA 
 (9.0 miles away)
310-825-5000
Languages Spoken:
English
See accepted insurances

Federico Velez is a Pediatrics provider in Los Angeles, California. Dr. Velez is highly rated in 10 conditions, according to our data. His top areas of expertise are Strabismus, Duane-Radial Ray Syndrome, Brown Syndrome, Tenotomy, and Cataract Removal.

Expertise in
9
conditions
Dr. Joseph Demer
Pediatrics
Expertise in
9
conditions
Dr. Joseph Demer
Pediatrics

Sherwin J. Isenberg MD Inc

100 Stein Plz, 
Los Angeles, CA 
 (9.0 miles away)
310-825-5931
Languages Spoken:
English
See accepted insurances

Joseph Demer is a Pediatrics provider in Los Angeles, California. Dr. Demer is highly rated in 9 conditions, according to our data. His top areas of expertise are Strabismus, Brown Syndrome, Esotropia, Amblyopia, and Tenotomy.

Expertise in
14
conditions
Dr. Rajsekar Rajaraman
Pediatrics
Expertise in
14
conditions
Dr. Rajsekar Rajaraman
Pediatrics

Ronald Reagan UCLA Medical Center

757 Westwood Plz, 
Los Angeles, CA 
 (9.2 miles away)
310-825-9111
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rajsekar Rajaraman is a Pediatrics provider in Los Angeles, California. Dr. Rajaraman is highly rated in 14 conditions, according to our data. His top areas of expertise are West Syndrome, Spasmus Nutans, CDKL5 Deficiency Disorder, and Tuberous Sclerosis.

Frequently Asked Questions about Dr. Donald Kohn

How do I make an appointment with Dr. Donald Kohn?

You can book an appointment with Dr. Donald Kohn by calling their office at 310-825-9111. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Donald Kohn a top-rated expert for Severe Combined Immunodeficiency (SCID)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Donald Kohn is classified as an Elite expert for Severe Combined Immunodeficiency (SCID), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Donald Kohn specialize in?

While Dr. Donald Kohn is a Pediatrics, they have specific expertise in Severe Combined Immunodeficiency (SCID), Adenosine Deaminase Deficiency, and X-Linked Severe Combined Immunodeficiency. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.

Does Dr. Donald Kohn participate in research or clinical trials?

Yes. Dr. Donald Kohn has published 199 articles and abstracts on conditions like Severe Combined Immunodeficiency (SCID). You can view a list of Dr. Donald Kohn's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Donald Kohn accept my insurance?

Dr. Donald Kohn accepts most major insurance plans, including Optima Health and UnitedHealthcare. We recommend calling the office directly at 310-825-9111 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kohn's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile